1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine,
ML 9,
ML-9,
ML-9,
105637-50-1,
ML 9 hydrochloride,
ML 9,
UNII-BZ2L6JK93I,
ML-9 hydrochloride,
ML-9, Hydrochloride,
1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine HCl,
BZ2L6JK93I,
1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride,
MFCD00065525,
1-(5-Chloronaphthalenesulfonyl)homopiperazine hydrochloride,
1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine,
1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride,
1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl,
1-(5-chloronaphthalen-1-ylsulfonyl)-1,4-diazepane hydrochloride,
1-(5-Chloronaphthalenesulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride [ML-9],
1H-1,4-Diazepine, 1-((5-chloro-1-naphthalenyl)sulfonyl)hexahydro-, monohydrochloride,
SR-01000075741,
C15H17ClN2O2S.HCl,
BMK1-E7,
AC1L338K,
SCHEMBL1848494,
CHEMBL1257075,
CTK8E8325,
DTXSID60147228,
OR7351T,
ZX-AT008912,
Tox21_500209,
IN1221,
NSC734549,
AKOS022180145,
ML-9, >=99% (TLC), powder,
CCG-221513,
LP00209,
NSC-734549,
VZ20991,
NCGC00093681-01,
NCGC00260894-01,
CC-02396,
LS-171976,
RT-013917,
B6300,
EU-0100209,
FT-0642604,
C 1172,
K00008,
C-20914,
J-001466,
SR-01000075741-1,
SR-01000075741-3,
1-(5-CHLORONAPHTHALENE-SULFONYL)HOMOPIPERAZINE,
1-(5-chloronaphthalenesulfonyl)homo piperazine hydrochloride,
ML-9; 1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl,
1-(5-chloronaphthalen-1-yl)sulfonyl-1,4-diazepane hydrochloride,
1H-1,4-Diazepine,1-[(5-chloro-1-naphthalenyl)sulfonyl]hexahydro-, hydrochloride (1:1),
C15H17ClN2O2S.ClH,
CID108047,
C15-H17-Cl-N2-O2S.Cl-H,
C056218,
1-(5-Chloronaphthalenesulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride,